Navigation Links
ERT Granted Patents on Clinical Trial Participant Compliance
Date:7/17/2012

PHILADELPHIA, July 17, 2012 /PRNewswire/ -- ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), today announced it has received two additional patents from the United States Patent and Trademark Office (U.S. Patent No. 8,065,180 and U.S. Patent No. 8,145,519).  The patents are titled System for Clinical Trial Subject Compliance and were acquired by ERT as part of the recent acquisition of invivodata.

"We are very pleased to be issued these additional patents," said Saul Shiffman, Ph.D., pioneer of the electronic patient reported outcomes industry, invivodata founder and one of the inventors of this intellectual property. "It is extremely rewarding to have our processes, which are based on proven scientific principles, be recognized in this manner and to see first-hand the benefits they are delivering to researchers who seek the most reliable and valid patient-centered data possible."

The patents announced today cover the tracking and enhancement of participant compliance with a research protocol and can also be used to provide evaluability data related to participant performance in a clinical trial.  Participant compliance is defined as the degree to which trial participants (patients and study team – including investigative site personnel) meet the expectations of the trial sponsor with regard to using a diary or other reporting mechanism to record answers to questions about their experiences during the trial.

Participant compliance with the research protocol is critical to ensuring the success of clinical trials.  ERT's electronic diary solutions - DIARYpro® for remote patient data collection, and SITEpro® (for site-based data collection) - are built on these patented compliance-enhancing methods and have been repeatedly proven to capture important COA data at the point of the participant's experience, y
'/>"/>

SOURCE ERT
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
2. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
3. CE Mark Granted for Wound Spray Based on Sangui Patent
4. Butamax Granted Core Patent for Making Biobutanol and Distillers Grains; Offers Producers Efficient, Low-Cost Production of Biobutanol
5. Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins
6. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
7. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
8. DNA2.0 Patents Key Method for Synthesizing Bioplastic Polymer
9. Olympus Licenses Digital Pathology Patents to Zeiss
10. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
11. Positive Clinical Study Results for BSPs HyperQ Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
(Date:1/14/2014)... 2014 iLab Solutions, the leader in core ... Director of Product Strategy. In this role, Michelle will work ... to guide in the development of iLab products. Her main ... possible benefit to the scientific community by offering the most ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... 30 DOR BioPharma, Inc. (OTC Bulletin Board: SNGX), a ... corporate name change from DOR BioPharma, Inc. to Soligenix, Inc. ... change, the Company,s shares of common stock will immediately begin ... , "We are pleased to announce the name ...
... STOCKHOLM, September 30 Nobelprize.org has ... official news about the 2009,Nobel Prize Announcements as soon as ... or Medicine, will be made on October 5, (see,the full ... exact,moment the announcements are made public in the following ways: ...
... 30 Amicus Therapeutics (Nasdaq: FOLD ) today announced ... (1-deoxynojirimycin HCl), its investigational drug in development for the treatment ... is to evaluate the pharmacokinetics of AT2220 in muscle tissue ... Administration (FDA) has agreed to Amicus, proposal for the Phase ...
Cached Biology Technology:DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 2DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 3DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 4Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements 2Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements 3Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 2Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 3Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 4
(Date:4/17/2014)... consumption advisories for expecting mothers are ineffective in ... organic pollutants (POPs). , The study, performed ... Toronto Scarborough PhD student Matt Binnington and Professor ... environmental contamination, a mother,s compliance with advisories, and ... exposure in her children. , Their model estimates ...
(Date:4/17/2014)... in about one per eight hundred births, Down syndrome ... genetic cause of intellectual disability. It results from a ... third copy of chromosome 21 (1% of the human ... team in the Department of Genetic Medicine and Development ... published in Nature , shed light on how ...
(Date:4/17/2014)... to produce hydrogen sulfide in order to properly multiply ... from the Center for Craniofacial Molecular Biology at the ... Songtao Shi, principal investigator on the project, said the ... the flow of calcium ions. The essential ions activate ... or the creation of new bone tissue, and keeps ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3
... released by the University of Minnesota Boynton Health Service ... nation to conduct a comprehensive survey on the health ... survey. Although the study is focused on students from ... national health trends for college students, says Dr. Ed ...
... 25% of Europes medium sized household appliances and 40% ... leaving substantial room for improvement, according to a study ... consortium. Small appliances, with a few exceptions, are close ... long-term collection rate targets of around 60% for small ...
... -- In response to the need for localized efforts ... threatened staghorn coral, Diego Lirman, Ph.D., and James Herlan, ... Marine and Atmospheric Science (RSMAS) have established an ... The goals of the coral nursery are to ...
Cached Biology News:University of Minnesota releases first ever comprehensive report of the health of college students 2University of Minnesota releases first ever comprehensive report of the health of college students 3University of Minnesota releases first ever comprehensive report of the health of college students 4University of Minnesota releases first ever comprehensive report of the health of college students 5Great potential to improve collection, recycling of Europe's electronic waste, says UN report 2Great potential to improve collection, recycling of Europe's electronic waste, says UN report 3New south Florida nursery to focus on staghorn corals 2